HENSLEE et al v. GlaxoSmithKline LLC
| KIMBERLY HENSLEE and STEVE HENSLEE |
| GlaxoSmithKline LLC |
| 1:2019cv12366 |
| November 18, 2019 |
| US District Court for the District of Massachusetts |
| F Dennis Saylor |
| Personal Inj. Prod. Liability |
| 28 U.S.C. ยง 1332 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 15, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 NOTICE re 1791 Motion Hearing set for 1/16/2020 at 10:30 AM. Counsel may attend the hearing by telephone. Please use the following dial-in information: DIAL IN: 1-888-675-2535, ACCESS CODE: 7629998. REMINDER: Your telephone line should be MUTED, so that you may hear the proceeding but other participants will not hear any background noise or interference. Please do not put your telephone on hold. Associated Cases: 1:15-md-02657-FDS et al.(Bono, Christine) |
| Filing 10 NOTICE re 1774 Status Conference and Motion Hearing set for 1/15/2020 at 10:00 AM. Counsel may attend the hearing by telephone. Please use the following dial-in information: DIAL IN: 1-888-675-2535, ACCESS CODE: 7629998. REMINDER: Your telephone line should be MUTED, so that you may hear the proceeding but other participants will not hear any background noise or interference. Please do not put your telephone on hold. Associated Cases: 1:15-md-02657-FDS et al. (Bono, Christine) |
| Filing 9 Electronic Clerk's Notes for proceedings held before Judge F. Dennis Saylor, IV: Status Conference held on 12/16/2019.1) The Court heard updates on the current total of federal and state filings.2) The Court heard the parties responses to its letter to the FDA, which was sent on December 13, 2019, regarding GSKs citizen petition (FDA-2019-P-5151-0001). 3) The Court heard updates on discovery regarding communications between GSK and Novartis. GSK made a supplemental production on December 13, 2019, and anticipates completing production by December 31, 2019. 4) The Court heard updates on discovery related to Dr. Zambelli-Weiners report. The parties currently intend to schedule her additional deposition for early January 2020.5) The Court set status conferences for 1/15/2020 10:00 a.m., 2/20/2020 1:30 p.m., and 3/18/2020 1:30 p.m. (Court Reporter: Linda Walsh at lwalshsteno@gmail.com.)(Attorneys present: Various) Associated Cases: 1:15-md-02657-FDS et al. (Bono, Christine) |
| Filing 8 NOTICE TO TELEPHONE PARTICIPANTS: Please use the following Participant line: (877) 876-9174 and Conference ID: Zofran, for the Status Conference set for 12/16/2019 at 1:30 PM. REMINDER: Counsel who wish to address the court by telephone must notify the courtroom deputy by email prior to the conference. Counsel who are not addressing the Court, please mute your telephones, so that you may hear the proceeding but other participants will not hear background noise or interference. Please do not put your telephone on hold. Associated Cases: 1:15-md-02657-FDS et al.(Bono, Christine) |
| Filing 7 NOTICE of Appearance by Jennifer M. Stevenson on behalf of GlaxoSmithKline LLC (Stevenson, Jennifer) |
| Filing 6 Electronic Clerk's Notes for proceedings held before Judge F. Dennis Saylor, IV: Status Conference held on 11/20/2019 in case 1:15-md-02657-FDS.1) The Court heard updates on the current total of federal and state filings. 2) The Court heard updates on Phase 5 discovery.3) The Court heard the parties proposals concerning the trial schedule in light of GSKs citizen petition pending before the FDA. a. With the agreement of the parties, the Court rescheduled the first bellwether trial, Rodriguez v. GSK, Case No. 1:15-cv-13762 to begin on May 4, 2020. b. The Court also stated that it was inclined to send a letter to the FDA about GSKs citizen petition. Any proposals from the parties about the content of that letter are due by December 2, 2019. c. Due to the revised trial schedule, the Court rescheduled the hearing on summary judgment and Daubert motions in Rodriguez for January 15, 2020 at 9:00 a.m. d. The Court will set revised dates for pretrial filings in Rodriguez.4) The Court heard argument on GSKs motion to compel plaintiffs to produce Dr. Louik for a targeted deposition on her supplemental report. (Dkt. No. 1691). For the reasons stated on the record, the motion is DENIED.5) A colloquy was held on GSKs request to depose Dr. Danielsson on his February 2019 supplemental report in light of the Courts order on GSKs motion to strike his report. (Dkt. Nos. 1425, 1703). To the extent that GSKs motion sought this relief, it remains under advisement. (Court Reporter: Valerie OHara at vaohara@gmail.com.)(Attorneys present: Various) Associated Cases: 1:15-md-02657-FDS et al.(Bono, Christine) |
| ELECTRONIC NOTICE of Duplicate Filing Fee and Credit for Refund, for $400.00 paid on 11/18/2019, receipt number 0101-7976089. (Tran, Henry) |
| Filing 5 ELECTRONIC NOTICE OF RESCHEDULING AS TO HEARING TYPE ONLY: Status Conference set for 11/20/2019 09:30 AM in Courtroom 2 before Judge F. Dennis Saylor IV. NOTICE TO TELEPHONE PARTICIPANTS: Please use the following Participant line: (877) 876-9177 and Conference ID: Zofran, for the Status Conference set for 11/20/2019 at 9:30 AM. REMINDER: Counsel who wish to address the court by telephone must notify the courtroom deputy by email prior to the conference. Counsel who are not addressing the Court, please mute your telephones, so that you may hear the proceeding but other participants will not hear background noise or interference. Please do not put your telephone on hold.Associated Cases: 1:15-md-02657-FDS et al. (Bono, Christine) |
| Filing 4 NOTICE OF MDL CASE OPENED, Direct file in the District of Massachusetts; Henslee, et al v. GlaxoSmithKline LLC. In Re: Zofran (Ondansetron) Products Liability Litigation, MDL 2657. (Finn, Mary) |
| Filing 3 Summons Issued as to GlaxoSmithKline LLC. Counsel receiving this notice electronically should download this summons, complete one for each defendant and serve it in accordance with Fed.R.Civ.P. 4 and LR 4.1. Summons will be mailed to plaintiff(s) not receiving notice electronically for completion of service. (McDonagh, Christina) |
| Filing 2 ELECTRONIC NOTICE of Case Assignment. Judge F. Dennis Saylor, IV assigned to case. (Finn, Mary) |
| Filing 1 COMPLAINT against GlaxoSmithKline LLC Filing fee: $ 400, receipt number 0101-7976149 (Fee Status: Filing Fee paid), filed by KIMBERLY HENSLEE, STEVE HENSLEE. (Attachments: #1 Civil Cover Sheet, #2 Case Category Form)(Millrood, Tobias) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Massachusetts District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
